Xlear says the move calls FTC’s authority to require clinical studies for non-pharmaceutical health products into question.

Nathan Jones, CEO of Xlear, Inc., Submits Testimony Supporting Robert F. Kennedy Jr.'s Nomination as Health and Human Services Secretary "The answer isn’t to censor science or restrict choices.

DOJ ASKS COURT TO DISMISS FTC-XLEAR LAWSUIT; Calls into Question FTC’s Authority to Require Clinical Studies for Non-Pharmaceutical Health Products ...

Reacting to the dismissal, Nathan Jones, CEO of Xlear, Inc. issued this statement: "We applaud the Department of Justice’s commonsense decision to drop this case—a case that had no merit and ...